| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $46.15M | $65.44M | $199.90M | $171.20M | $169.82M |
| R&D | $30.75M | $12.34M | $133.07M | $118.87M | $120.73M |
| SG&A | $15.40M | $42.92M | $48.26M | $52.33M | $49.08M |
| Operating Income | -$46.15M | -$65.44M | -$199.90M | -$171.20M | -$169.82M |
| Interest Expense | $1.44M | $2.70M | – | – | – |
| Tax Expense | $0.00 | $0.00 | -$126.00K | -$265.00K | $1.01M |
| Net Income | -$43.44M | -$58.77M | -$190.42M | -$168.71M | -$171.96M |
| EPS (basic) | -2.8500 | -11.7300 | -1.8300 | -2.2000 | -2.7400 |
| EPS (diluted) | -2.8500 | -11.7300 | -1.8300 | -2.2000 | -2.7400 |
| Shares (diluted) | $15.27M | $5.01M | $104.06M | $76.65M | $62.78M |